Heart Test Laboratories (NASDAQ:HSCS – Get Free Report) posted its earnings results on Thursday. The company reported ($2.57) earnings per share for the quarter, missing the consensus estimate of ($2.53) by ($0.04), Zacks reports.
Heart Test Laboratories Trading Down 4.6 %
Heart Test Laboratories stock opened at $2.91 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.52 and a current ratio of 1.72. The business’s 50-day simple moving average is $3.45 and its 200-day simple moving average is $3.43. The firm has a market capitalization of $2.85 million, a PE ratio of -0.37 and a beta of 2.76. Heart Test Laboratories has a 52 week low of $2.36 and a 52 week high of $13.50.
Wall Street Analysts Forecast Growth
Separately, Maxim Group reiterated a “buy” rating and issued a $12.00 price objective on shares of Heart Test Laboratories in a research note on Wednesday, December 18th.
About Heart Test Laboratories
Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.
Featured Stories
- Five stocks we like better than Heart Test Laboratories
- Business Services Stocks Investing
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- The Risks of Owning Bonds
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
- Short Selling: How to Short a Stock
- Why Costco Stock Is Poised to Hit $1,000 Again Soon
Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
